LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Congress Asset Management Co.

Congress Asset Management Co. grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 1.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 722,325 shares of the medical instruments supplier’s stock after purchasing an additional 13,009 shares during the quarter. Congress Asset Management Co.’s holdings in LeMaitre Vascular were worth $66,555,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Conestoga Capital Advisors LLC lifted its position in shares of LeMaitre Vascular by 1.9% during the third quarter. Conestoga Capital Advisors LLC now owns 1,978,351 shares of the medical instruments supplier’s stock worth $183,769,000 after purchasing an additional 36,850 shares during the last quarter. Copeland Capital Management LLC lifted its holdings in LeMaitre Vascular by 0.7% during the 4th quarter. Copeland Capital Management LLC now owns 1,172,015 shares of the medical instruments supplier’s stock worth $107,990,000 after buying an additional 8,623 shares during the last quarter. State Street Corp grew its position in shares of LeMaitre Vascular by 3.6% in the 3rd quarter. State Street Corp now owns 822,085 shares of the medical instruments supplier’s stock worth $76,363,000 after acquiring an additional 28,525 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of LeMaitre Vascular by 4.5% in the 3rd quarter. Geode Capital Management LLC now owns 542,523 shares of the medical instruments supplier’s stock valued at $50,403,000 after acquiring an additional 23,443 shares during the last quarter. Finally, Rice Hall James & Associates LLC raised its position in shares of LeMaitre Vascular by 15.7% during the 3rd quarter. Rice Hall James & Associates LLC now owns 261,306 shares of the medical instruments supplier’s stock valued at $24,273,000 after acquiring an additional 35,383 shares in the last quarter. Institutional investors own 84.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on LMAT. StockNews.com lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Wells Fargo & Company assumed coverage on shares of LeMaitre Vascular in a research report on Thursday. They set an “equal weight” rating and a $95.00 price objective for the company. Oppenheimer reissued an “outperform” rating and issued a $93.00 target price (up previously from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. Finally, Barrington Research increased their price target on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, LeMaitre Vascular has an average rating of “Moderate Buy” and an average target price of $94.63.

LeMaitre Vascular Price Performance

Shares of LMAT stock opened at $98.65 on Friday. The business has a 50 day simple moving average of $95.94 and a 200 day simple moving average of $93.61. The firm has a market capitalization of $2.22 billion, a price-to-earnings ratio of 53.91, a price-to-earnings-growth ratio of 2.19 and a beta of 0.96. LeMaitre Vascular, Inc. has a 12-month low of $59.87 and a 12-month high of $109.58.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.